Antiviral action of the tumor suppressor ARF

被引:42
作者
Garcia, Maria A.
Collado, Manuel
Munoz-Fontela, Cesar
Matheu, Ander
Marcos-Villar, Laura
Arroyo, Javier
Esteban, Mariano
Serrano, Manuel
Rivas, Carmen
机构
[1] CNIO, Madrid 28029, Spain
[2] Univ Autonoma Madrid, Ctr Nacl Biotecnol, Madrid, Spain
[3] Univ Complutense Madrid, Dept Microbiol 2, Madrid, Spain
关键词
antiviral activity; IFN; ARF; NPM; PKR;
D O I
10.1038/sj.emboj.7601302
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oncogenic viruses frequently target the pathways controlled by tumor suppressor genes, suggesting an extra function for these proteins as antiviral factors. The control exerted by the tumor suppressor Arf on cellular proliferation is crucial to restrict tumor development; however, a potential contribution of Arf to prevent viral infectivity has remained unexplored. In the present study, we investigated the consequences of loss or increased expression of Arf on viral infection. Our results reveal that ARF expression is induced by interferon and after viral infection. Furthermore, we show that ARF protects against viral infection in a gene dosage-dependent manner, and that this antiviral action is mediated in part by PKR through a mechanism that involves ARF-induced release of PKR from nucleophosmin complexes. Finally, Arf-null mice were hypersensitive to viral infection compared to wildtype mice. Together, our results reveal a novel and unexpected role for the tumor suppressor ARF in viral infection surveillance.
引用
收藏
页码:4284 / 4292
页数:9
相关论文
共 53 条
[1]   A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION [J].
ALCAMI, A ;
SMITH, GL .
CELL, 1992, 71 (01) :153-167
[2]   DISTINCT PATTERNS OF IFN SENSITIVITY OBSERVED IN CELLS INFECTED WITH VACCINIA K3L(-) AND E3L(-) MUTANT VIRUSES [J].
BEATTIE, E ;
PAOLETTI, E ;
TARTAGLIA, J .
VIROLOGY, 1995, 210 (02) :254-263
[3]   Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23 [J].
Bertwistle, D ;
Sugimoto, M ;
Sherr, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) :985-996
[4]   Pondering the promyelocytic leukemia protein (PML) puzzle: Possible functions for PML nuclear bodies [J].
Borden, KLB .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5259-5269
[5]   ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway [J].
Brady, SN ;
Yu, Y ;
Maggi, LB ;
Weber, JD .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (21) :9327-9338
[6]   Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model [J].
Brandt, TA ;
Jacobs, BL .
JOURNAL OF VIROLOGY, 2001, 75 (02) :850-856
[7]   Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein [J].
Chelbi-Alix, MK ;
Quignon, F ;
Pelicano, L ;
Koken, MHM ;
De Thé, H .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1043-1051
[8]   CELL-CYCLE PHASE-DEPENDENT CHANGES OF LOCALIZATION AND OLIGOMERIZATION STATES OF NUCLEOPHOSMIN/B23 [J].
CHOU, YH ;
YUNG, BYM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 217 (01) :313-325
[9]   Tumour biology -: Senescence in premalignant tumours [J].
Collado, M ;
Gil, J ;
Efeyan, A ;
Guerra, C ;
Schuhmacher, AJ ;
Barradas, M ;
Benguría, A ;
Zaballos, A ;
Flores, JM ;
Barbacid, M ;
Beach, D ;
Serrano, M .
NATURE, 2005, 436 (7051) :642-642
[10]   Human tumor suppressor p53 and DNA viruses [J].
Collot-Teixeira, S ;
Bass, J ;
Denis, F ;
Ranger-Rogez, S .
REVIEWS IN MEDICAL VIROLOGY, 2004, 14 (05) :301-319